FRANKFURT--The following is a summary of analysts' forecasts for GlaxoSmithKline plc (GSK) second-quarter results, based on a poll of six analysts conducted by Dow Jones Newswires (figures in million pound, EPS and target price in pence, according to IFRS). Earnings figures are scheduled to be released July 23.

=== 
                                                Core 
                              Core               Net 
                Turnover   operat.    Core   attrib.   Core 
2nd Quarter        total    profit     PBT    profit    EPS 
AVERAGE            5,737     1,574   1,414     1,037   21.6 
Prev. Year         6,373     1,878   1,702     1,230   25.3 
+/- in %             -10       -16     -17       -16    -15 
 
MEDIAN             5,724     1,580   1,419     1,042   21.7 
Maximum            5,828     1,596   1,436     1,050   21.8 
Minimum            5,650     1,543   1,381     1,009   21.0 
Amount (a)             6         6       5         5      6 
 
Bernstein          5,828     1,596   1,429     1,050   21.8 
Deutsche Bank      5,672     1,586   1,419     1,042   21.7 
Exane BNP Paribas  5,672     1,543   1,381     1,009   21.0 
Helvea             5,775     1,573   1,436     1,048   21.8 
Kepler Cheuvreux   5,827     1,586      --        --   21.7 
 
 
            Target price   Rating 
 
AVERAGE            1,668   positive 1 
Prev. Quarter      1,625   neutral  4 
+/- in %            +2.7   negative 0 
 
MEDIAN             1,650 
Maximum            1,800 
Minimum            1,600 
Amount                 6 
 
Bernstein          1,650   Market perform 
Deutsche Bank      1,630   Hold 
Exane BNP Paribas  1,600   -- 
Helvea             1,680   Hold 
Kepler Cheuvreux   1,800   Buy 
Panmure Gordon     1,650   Hold 
=== 

Year-earlier figures are as restated by the company.

(a) Including anonymous estimates from one more analyst.

DJG/voi 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires